Biochemical Assays, Cell Based Assays and DNA

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Biochemical Assays

Cell Based Assays

DNA

Article FDA Thank You Draft guidance on potency assays for CGT products garners extensive stakeholder input

Agency IQ

APRIL 12, 2024

For example, in describing how potency should be demonstrated for CGT products, the 2011 guidance simply stated that potency for gene therapy products is derived from “at least two biological activities for its potency: the ability to transfer a genetic sequence to a cell; and the biological effect of the expressed genetic sequence.”

Production

Production FDA Therapies Biochemical Assays

Transforming high-throughput screening with mass spectrometry

Drug Discovery World

OCTOBER 14, 2022

Trapped ion mobility spectrometry: Improving the specificity of MALDI-MS-based HTS . Büttner, MALDI-TOF mass spectrometry-based high-throughput screening for inhibitors of the cytosolic DNA sensor cGAS, SLAS Discovery, 2020, 25: 372–383, [link]. Weigt, C.A. Parrish, J.A. Krueger, C.A. Oleykowski, A.R. Rendina and C.

Synthetic Chemistry

Synthetic Chemistry Cell Based Assays Biochemical Assays Analytical Chemistry

Drug Discovery Digest

Article FDA Thank You Draft guidance on potency assays for CGT products garners extensive stakeholder input

Transforming high-throughput screening with mass spectrometry

Stay Connected